Our Services
Pre-clinical services
PANGAEA LAB integrates advanced molecular diagnostics with preclinical cancer research to generate clinically relevant, translational insights that support oncology drug development and biomarker strategies.
Our multidisciplinary team combines expertise in tumor biology, molecular profiling and functional validation, enabling a seamless connection between patient-derived data and preclinical models.
In-house and through partnerships we perform comprehensive pathology, molecular biology, in-vitro and in-vivo techniques:
- Study of in-vitro effects of drugs and vaccines
- 2D and 3D cell culturing
- MTT proliferation assays
- Flow cytometry
- Colony formation, migration and invasion assays
- Generation of primary cultures derived from patient material (fresh biopsies and malignant effusions) and private collection of over 300 cellular models with clinically relevant molecular alterations.
- Service & idea providers for the development of new anti-cancer drugs
- Characterization of different cellular models using molecular techniques (FISH, NGS etc.)
- Development of cell lines resistant to drugs on the market
- In-vivo mice models
- Biomarker Discovery linked to drug sensitivity
- Gene silencing (lentivirus transfection, CRISPR)
